FindTrial
Sign In

mortality benefit of isolating patients infected with multidrug-resistant organisms in ICU

Effectiveness of Isolation of Patients Infected with Multidrug-Resistant Organisms on Mortality in the ICU: A Prospective Cohort Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097422
Enrollment
300
Registered
2025-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B998- Other infectious disease

Interventions

Intervention1: Nil: Nil

Sponsors

pradeep
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults more than or equal to 18 years of age admitted to MICU and Pulmonology ICU. 2. Patients identified with MDR infection at admission or during hospitalization.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
mortality of any causeTimepoint: 18 months—

Secondary

MeasureTime frame
length of ICU stay 3 month risk of readmission or death Timepoint: 18 months—

Countries

India

Contacts

Public Contactpradeep

AIIMS Rishikesh

motherprasanna@rediffmail.com9868999488

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026